Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinical Research for CEOs: A guide to good business practice and the conduct of clinical trials.

This article was originally published in Clinica

Executive Summary

Regulations do not always provide answers to how best conduct clinical trials. The US's Investigational Device Exemptions (IDEs) and Europe's regulations governing trials to establish device performance in support of obtaining a CE marking (EN 540) give only the sketchiest guidance. Nor are all clinical trials regulated. By stating that trials conducted in support of obtaining a CE marking are subject to EN540, Europe's Active Implantable Medical Directive and Medical Directive leave, by inference, trials conducted for other purposes free from the need to comply with EN540. In the US, IDE's actually provide for exempt clinical trials. In general, such unregulated trials are those conducted on commercial devices used in accordance with approved labelling, trials conducted to determine characteristics other than safety, efficacy or performance, or trials conducted on in vitro diagnostic devices. In these cases the regulations either do not provide guidance or they do not apply at all, and each manufacturer is left to determine how the ethics of good clinical practices will be applied to sponsored clinical research. The following are the most frequently asked about clinical trials.

You may also be interested in...



Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel